Rhino Propels Federated AI into the Enterprise Tech Stack Turnium Technology Group, Inc. Announces Closing of Brokered and Non-Brokered LIFE Offering For Gross Proceeds of C$3 Million
Vancouver, Canada–(Newsfile Corp. – August 3, 2023) – Turnium Technology Group, Inc. (TSXV: TTGI), (the…
VYRE Network Creates Business News Channel (VBNG TV) to Empower Today’s Small-Cap Companies, Business Leaders, and Brand Partners Enhanced by AI Technology
Los Angeles, California–(Newsfile Corp. – August 3, 2023) – VYRE Network (a free global streaming…
Holn Gaming Proves Itself as the Best Esports Club From Lombok, Indonesia
MATARAM, INDONESIA, Aug 3, 2023 – (ACN Newswire) – Online games are one of the…
MCE Systems – an Amazon Web Service Qualified Software Partner – Joins the AWS Partner Network
MCE completes the AWS Foundational Technical Review to meet AWS’ high standards for reliability, security,…
PCTEL Announces New Innovative 5G FR1 Omnidirectional Antenna for Industrial IoT Applications
Reliable Connectivity Even in the Harshest Environments BLOOMINGDALE, Ill.–(BUSINESS WIRE)–#5GAntenna–PCTEL, Inc. (Nasdaq: PCTI), a leading…
Pinnacle West Reports Lower 2023 Second-Quarter Financial Results
Mild weather and higher operating costs impact earnings APS supports customers through the summer season…
Flux Power Closes New $15 Million Credit Facility with Gibraltar Business Capital
New Facility Lowers Interest Expense, Expands Term & Provides Additional Capital Based on Company Milestone…
The Growth of Virtual Reality Technology: From a Dream to a Reality of Its Own
By Vasily Petrenko, CEO — Another World VR “Immersive” is a term typically used to…
Elevar Therapeutics to Host August 10 Virtual KOL Event on Phase 3 Study of Rivoceranib in Combination with Camrelizumab in Unresectable Hepatocellular Carcinoma (uHCC)
FORT LEE, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…
Elevar Therapeutics to Host August 10 Virtual KOL Event on Phase 3 Study of Rivoceranib in Combination with Camrelizumab in Unresectable Hepatocellular Carcinoma (uHCC)
FORT LEE, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary…
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023
MIAMI, Aug. 03, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…
Fortress Biotech to Present at the BTIG Virtual Biotechnology Conference 2023
MIAMI, Aug. 03, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative…
Veru to Report Fiscal 2023 Third Quarter Financial Results on August 10, 2023
MIAMI, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical…
Veru to Report Fiscal 2023 Third Quarter Financial Results on August 10, 2023
MIAMI, FL, Aug. 03, 2023 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical…
IMUNON to Hold Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 10, 2023
LAWRENCEVILLE, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development…
IMUNON to Hold Second Quarter 2023 Financial Results and Business Update Conference Call on Thursday, August 10, 2023
LAWRENCEVILLE, N.J., Aug. 03, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development…
GRI Bio (NASDAQ: GRI) to Present at Benzinga’s Virtual Biotech Conference
– Live moderated webcast fireside chat today, August 3rd at 11:15 AM ET LA JOLLA,…
GRI Bio (NASDAQ: GRI) to Present at Benzinga’s Virtual Biotech Conference
– Live moderated webcast fireside chat today, August 3rd at 11:15 AM ET LA JOLLA,…
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
HOUSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (Nasdaq:BPTH) (“Bio-Path” or the “Company”),…
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
HOUSTON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (Nasdaq:BPTH) (“Bio-Path” or the “Company”),…